For us, everything starts with people
Insmed (insmed.com) scores 83 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 88th percentile of 19087 Healthcare brands.
Insmed is a biopharmaceutical company headquartered in Bridgewater Township, United States, founded in 1988. The company focuses on understanding the experiences of people living with serious and rare diseases and developing innovative therapies to address their unmet medical needs. Insmed emphasizes patient-centric drug development, combining scientific innovation with engagement from patient communities, healthcare providers, researchers, and the broader medical and scientific community to drive meaningful change for underserved disease populations.
| Brand Name | Insmed |
|---|---|
| Domain | insmed.com |
| Industry | Healthcare |
| Founded | 1988 |
| Headquarters | Bridgewater Township |
| Main Competitors | Vertex Pharmaceuticals (88/100), Alexion Pharmaceuticals (87/100), BioMarin Pharmaceutical (84/100), Sarepta Therapeutics (83/100), Ultragenyx Pharmaceutical (79/100), Horizon Therapeutics (80/100) |
Moz Domain Authority 46/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #439,843 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "We work hard to understand the experiences of those living with serious diseases as we strive to deliver true change." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, YouTube, Instagram, X (Twitter), GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Insmed?", Claude could identify the brand as of October 2026. Insmed is a biopharmaceutical company focused on developing therapies for serious and rare diseases, particularly in pulmonology. It's best known for ARIKAYCE, a treatment for nontuberculous mycobacterial (NTM) lung disease, and has a pipeline targeting conditions like bronchiect Best known for Developing ARIKAYCE, the first FDA-approved treatment for refractory nontuberculous mycobacterial (NTM) lung disease.
When asked "Best brands similar to Insmed?", Claude would recommend Insmed as of October 2026. It's a notable name in rare disease and pulmonology-focused biopharma, so I'd mention it when discussing companies specializing in orphan drugs or respiratory disease treatments.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Insmed's main competitors in Healthcare: Vertex Pharmaceuticals (88/100), Alexion Pharmaceuticals (87/100), BioMarin Pharmaceutical (84/100), Sarepta Therapeutics (83/100), Ultragenyx Pharmaceutical (79/100).
Sources: Brand Analyzer scan
Insmed has limited AI-search visibility, scoring 37/100 on Brand Analyzer's AI visibility composite (visibility 28, trust 36, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Insmed official site
Insmed was founded in 1988. Insmed operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Insmed is headquartered in Bridgewater Township. Insmed operates in the Healthcare category.
Sources: Wikidata
Insmed scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Insmed official site
Insmed is a biopharmaceutical company headquartered in Bridgewater Township, United States, founded in 1988. It is dedicated to developing innovative therapies for people living with serious and rare diseases, with a strong emphasis on patient-centric drug development and engagement with patient communities.
Sources: Insmed official site
Insmed can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Insmed official site
Insmed develops innovative therapies aimed at addressing serious and underserved diseases. The company works closely with patient communities to understand their experiences and uses this insight to guide scientific research and drug development, with the goal of delivering meaningful change for patients, healthcare providers, and the broader medical and scientific community.
Sources: Insmed official site
Insmed's work is intended for patients living with serious and rare diseases, as well as healthcare providers, researchers, and members of the broader medical and scientific community who engage with the company's therapies and research.
Sources: Insmed official site
Insmed scores 37/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Insmed has a weak AI-visibility profile at 37/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (28/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #439,843 (Tranco) and a Moz Domain Authority of 46/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Insmed from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Insmed: Insilico Medicine (83/100), InMode (83/100), Instahelp (83/100), IntelyCare (83/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.